You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nubeqa

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Prostate Cancer Trial in Worldwide (AZD5305, Darolutamide, No Treatment)

Not yet recruiting
  • Prostate Cancer
  • Melbourne, Australia
  • +7 more
Jul 3, 2023

Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

Not yet recruiting
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 6, 2023

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

Not yet recruiting
  • Prostate Cancer
  • Darolutamide Oral Tablet [Nubeqa]
  • (no location specified)
Jun 2, 2023

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jan 13, 2023

Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

Not yet recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 14, 2022

Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)

Recruiting
  • Prostate Cancer
  • Brasília, Distrito Federal, Brazil
  • +4 more
Dec 22, 2022

Prostate Cancer Trial in Nanning (Darolutamide 300 mg, Androgen deprivation therapy)

Not yet recruiting
  • Prostate Cancer
  • Darolutamide 300 mg
  • Androgen deprivation therapy
  • Nanning, Jiangsu, China
    Hongqian Guo
Feb 19, 2022

Prostatic Cancer, Castration-Resistant Trial in United States (Darolutamide(Nubeqa, BAY1841788), Enzalutamide)

Completed
  • Prostatic Cancer, Castration-Resistant
  • Portland, Maine
  • +6 more
Aug 18, 2022

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Advanced Prostate Carcinoma, Cancer of Prostate, PSA Trial in Melbourne (Darolutamide, Radiotherapy)

Recruiting
  • Advanced Prostate Carcinoma
  • +3 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Center
Aug 26, 2021

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (Darolutamide (BAY1841788, Nubeqa), ADT)

Recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Darolutamide (BAY1841788, Nubeqa)
  • ADT
  • Homewood, Alabama
  • +11 more
Jan 13, 2023

Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +3 more
  • San Diego, California
  • +11 more
Nov 28, 2022

Metastatic Prostate Cancer Trial in Australia, United Kingdom (AZD5305, Enzalutamide, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • San Diego, California
  • +25 more
Jan 10, 2023

Non-metastatic Castration-resistant Prostate Cancer Trial in India (Darolutamide (Nubeqa, BAY1841788))

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • Hyderabad, Andhra Pradesh, India
  • +22 more
Jul 29, 2022

Prostate Cancer Metastatic Trial in France (Darolutamide 300 mg, Placebo, Androgen deprivation therapy)

Recruiting
  • Prostate Cancer Metastatic
  • Darolutamide 300 mg
  • +2 more
  • Avignon, France
  • +44 more
Sep 28, 2022

Prostatic Tumors Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788), Placebo, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Prostatic Neoplasms
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Macquarie University, New South Wales, Australia
  • +131 more
Jan 5, 2023

Biochemically Recurrent Prostate Cancer Trial in Worldwide (Darolutamide (BAY1841788, Nubeqa), Placebo matching darolutamide,

Not yet recruiting
  • Biochemically Recurrent Prostate Cancer
  • Darolutamide (BAY1841788, Nubeqa)
  • +2 more
  • Phoenix, Arizona
  • +183 more
Mar 21, 2023

Cancer Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788))

Recruiting
  • Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • Homewood, Alabama
  • +335 more
Aug 8, 2022